Trial Profile

Comparative Evaluation of QUEtiapine-Lamotrigine combination versus quetiapine monotherapy (and folic acid versus placebo) in people with bipolar depression

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 25 Jul 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Lamotrigine (Primary) ; Folic acid; Quetiapine
Indications Bipolar I disorders; Bipolar II disorders
Focus Therapeutic Use
Acronyms CEQUEL

Most Recent Events

30 Jan 2014 According to UKCRN record accrual to date is 89%
23 Dec 2013 Planned number of patients changed from 584 to 202 as reported by ISRCTN.
30 Jun 2012 New source identified and integrated (European Clinical Trials Database; EudraCT2007-004513-33).

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com